在临床实践中降低质子抑制剂的处方方法:系统性审查
Andrea Rossi1,2, Lara Perrella3, Stefano Scotti2
1Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
Journal of clinical medicine
|October 26, 2024
概括
质子抑制剂 (PPI) 减记是由于不适当使用而至关重要的. 有效的策略涉及医疗保健协作,算法和患者输入,逐渐减少对轻度症状有益,并防止反弹效应.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 基于证据的医学基于证据的医学.
背景情况:
- 质子抑制剂 (PPI) 被广泛处方,往往不恰当,导致建议减轻处方.
- 由于各种策略和设置,在执行PPI描述过程中存在挑战.
研究的目的:
- 在各种环境和医疗保健专业人员中系统地审查和概述PPI治疗干预措施.
- 确定PPI的有效策略,去处方实施和患者的结果.
主要方法:
- 从PubMed,Embase和Web of Science (1989-2024) 的文献进行系统的审查.
- 纳入评估成人患者的PPI降低处方效果的研究,重点关注实施率和症状影响.
- 主要的研究设计包括实用试验 (N=32) 和随机对照试验 (N=25).
主要成果:
- 确定了各种干预措施来促进PPI抑郁症.
- 协作多学科方法,决策算法和患者参与是有效策略的关键.
- 按需治疗可能适用于复发症状;逐渐减缓对缓和条件有效,以减轻反弹.
结论:
- 提高医生和患者对PPI处方减缓的认识是必不可少的,因为广泛的不适当的处方.
- 处方策略必须是个性化的,考虑患者的病史,健康状况和偏好.
- 量身定制的降低处方方法对于优化药物使用和患者护理至关重要.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
360
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
360
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Antidepressant Drugs: Overview
370
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
370
Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
407
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
407
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328


